Chemplast Sanmar (CHEMPLASTS) Q4 18/19 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 18/19 earnings summary
14 Oct, 2026Executive summary
FY19 PBT before exceptional items rose 10% YoY to Rs 232.45 crore, driven mainly by improved Chloromethanes margins; PAT was Rs 187.21 crore.
The scheme transferred Suspension PVC operations to Chemplast Cuddalore Vinyls Limited and merged Sanmar Speciality Chemicals Limited effective from the appointed date of 1 April 2018.
Financial highlights
Sales and other income were Rs 1,269.83 crore versus restated Rs 1,152.61 crore; PBT before exceptional items was Rs 232.45 crore versus Rs 211.46 crore.
Net profit was Rs 187.21 crore versus restated Rs 88.84 crore; FY19 included a Rs 15.10 crore exceptional gain from reversal of employee separation compensation provision.
Finance costs were Rs 46.99 crore versus Rs 37.43 crore, while depreciation was Rs 54.88 crore versus Rs 57.00 crore.
Outlook and guidance
FY20 PVC Paste Resin volumes are expected to maintain market share; tight availability after Korean and Chinese plant shutdowns is expected to support firm prices.
Chloromethanes prices are expected to moderate from FY19 peaks; improved PVC Paste Resin margins are expected to support overall performance.
Caustic imports may rise after BIS registrations, creating expected downward price pressure; custom intermediates development is intended to improve Specialty Chemicals performance in coming years.
Latest events from Chemplast Sanmar
- Record pre-exceptional PBT rose 7% as Cuddalore margins and lower costs lifted results.CHEMPLASTS
Q4 17/18 - EBITDA margin rose to 30.7%; consolidated profit included major investment-redemption gains.CHEMPLASTS
Q4 20/21 - Higher depreciation, finance costs and COVID-19 pressure drove a sharp FY20 profit decline.CHEMPLASTS
Q4 19/20 - Record FY22 performance and IPO-led deleveraging fund the next capacity-growth phase.CHEMPLASTS
Q4 21/22 - Price and energy pressure cut FY23 earnings as major growth projects advanced.CHEMPLASTS
Q4 22/23 - Revenue rose 2% YoY but EBITDA turned negative amid high costs and market pressures.CHEMPLASTS
Q1 26/27 - Q1 FY25 saw strong revenue and profit growth, led by specialty chemicals and CMC expansion.CHEMPLASTS
Q1 24/25 - FY25 revenue and EBITDA surged, led by specialty chemicals; net loss narrowed despite PVC headwinds.CHEMPLASTS
Q4 24/25 - Q1 FY26 saw a 4% YoY revenue drop, net loss, and one-time tax and revaluation impacts.CHEMPLASTS
Q1 25/26